March 4, 2015
Taiho Pharmaceutical said on March 2 that its European subsidiary Taiho Pharma Europe filed on February 27 (local time) a marketing authorization application for its fixed-dose combination tablet containing trifluridine and tipiracil (brand name in Japan: Lonsurf) with the European...read more